Viva Biotech Holdings (HKG:1873)

Hong Kong · Delayed Price · Currency is HKD

1.280

-0.050 (-3.76%)

Sep 11, 2026, 4:08 PM HKT

Revenue by Segment

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
Viva Bioinnovator	9.31M	18.09M	30.61M	-	-
Contract Development Manufacture Organisation (CDMO) and Commercialisation Services	894.11M	1.18B	1.31B	1.48B	1.36B
Drug Discovery Services	854.72M	821.31M	866.76M	895.06M	740.47M
Elimination	-28.69M	-32.09M	-56.54M	-	-
Total	1.73B	1.99B	2.16B	2.38B	2.10B

Revenue by Geography

Financials in millions CNY. Fiscal year is January - December.

Millions CNY. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	FY 2018	FY 2017	FY 2016
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	Dec '18 Dec 31, 2018	Dec '17 Dec 31, 2017	Dec '16 Dec 31, 2016
United States of America (USA)	830.80M	795.83M	812.79M	915.82M	646.52M
Europe	461.28M	623.34M	589.56M	508.47M	590.23M
Chinese Mainland	259.65M	267.23M	323.67M	382.38M	376.74M
Other Asia countries and regions out of Chinese Mainland	92.27M	193.53M	291.39M	392.80M	330.08M
Africa	17.82M	45.27M	45.03M	64.55M	74.18M
Others	67.63M	61.47M	93.14M	115.62M	86.34M
Total	1.73B	1.99B	2.16B	2.38B	2.10B